About this FactMed analysis covering adverse side effect reports of SALOSPIR (ACETYLSALICYLIC ACID) patients who developed PREGNANCY.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking SALOSPIR (ACETYLSALICYLIC ACID) reported PREGNANCY to the FDA. A total of 27 SALOSPIR (ACETYLSALICYLIC ACID) drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between SALOSPIR (ACETYLSALICYLIC ACID) and PREGNANCY. In doing so, we compare SALOSPIR (ACETYLSALICYLIC ACID) with other drugs that cause PREGNANCY, to help you evaluate whether or not SALOSPIR (ACETYLSALICYLIC ACID) causes PREGNANCY. Likewise, this page shows the most highly-reported side effects of SALOSPIR (ACETYLSALICYLIC ACID), so you can see if PREGNANCY ranks among SALOSPIR (ACETYLSALICYLIC ACID)'s most well-known side effects.
Summary Statistics
Reports of SALOSPIR (ACETYLSALICYLIC ACID) causing PREGNANCY: 2
Reports of any side effect of SALOSPIR (ACETYLSALICYLIC ACID) : 27
Percentage of SALOSPIR (ACETYLSALICYLIC ACID) patients where PREGNANCY is a reported side effect: 7.4074%

FDA reports of any drug causing PREGNANCY : 15429
Average percentage for all medicated patients where PREGNANCY is reported as a complication: 0.0967%

Physician opinion on SALOSPIR (ACETYLSALICYLIC ACID) as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing SALOSPIR (ACETYLSALICYLIC ACID):
( 0 patients )
Drugs with high FDA adverse event association with PREGNANCY:

ISOTRETINOIN (2442 patients)
ACCUTANE (1590 patients)
ABILIFY (725 patients)
KEPPRA (587 patients)
FOLIC ACID (508 patients)
TYSABRI (507 patients)
AMNESTEEM (467 patients)
ROACUTAN (442 patients)
TRUVADA (399 patients)
MISOPROSTOL (383 patients)
MIRENA (361 patients)
AVONEX (347 patients)
COMBIVIR (345 patients)
TAMIFLU (345 patients)
TRACLEER (327 patients)
PRENATAL VITAMINS (304 patients)
ROACCUTANE (302 patients)
NORVIR (278 patients)
PROGRAF (274 patients)
SUSTIVA (274 patients)
NUVARING (273 patients)
REYATAZ (269 patients)
REBIF (255 patients)
KALETRA (254 patients)
CLARAVIS (253 patients)
ORAL CONTRACEPTIVE PILL (ORAL CONTRACEPTIVE NOS) (246 patients)
MIFEPRISTONE TABLETS, 200 MG (DANCO LABS) (225 patients)
ZOLOFT (214 patients)
LEXAPRO (201 patients)
CIMZIA (200 patients)
LAMIVUDINE (198 patients)
RITONAVIR (193 patients)
PREDNISONE (188 patients)
ZIDOVUDINE (188 patients)
LAMICTAL (186 patients)
EFAVIRENZ (183 patients)
RETROVIR (178 patients)
PREDNISONE TAB (174 patients)
DOXYCYCLINE (171 patients)
VIREAD (165 patients)
COUMADIN (162 patients)
LEVETIRACETAM (161 patients)
REMICADE (159 patients)
SEROQUEL (158 patients)
YASMIN (148 patients)
ASPIRIN (145 patients)
NEVIRAPINE (142 patients)
VITAMIN TAB (138 patients)
EPIVIR (137 patients)
ATAZANAVIR (136 patients)
VIRACEPT (127 patients)
ENBREL (126 patients)
CITALOPRAM HYDROBROMIDE (126 patients)
LAMOTRIGINE (122 patients)
PREDNISOLONE (121 patients)
ROACCUTAN (120 patients)
METFORMIN HCL (117 patients)
SYNTHROID (117 patients)
VIRAMUNE (115 patients)
CELEXA (114 patients)
ESCITALOPRAM (113 patients)
SINGULAIR (111 patients)
VIDEX (110 patients)
METHOTREXATE (110 patients)
ACETAMINOPHEN (109 patients)
SOLIRIS (109 patients)
BARACLUDE (105 patients)
MULTI-VITAMINS (103 patients)
EFFEXOR (102 patients)
CLONAZEPAM (99 patients)
PAXIL (98 patients)
ZERIT (97 patients)
MIFEPRISTONE (MIFEPREX) (97 patients)
AZATHIOPRINE (96 patients)
YAZ (96 patients)
STAVUDINE (91 patients)
CELLCEPT (91 patients)
ORTHO TRI-CYCLEN (90 patients)
ZYPREXA (87 patients)
IBUPROFEN (85 patients)
DIDANOSINE (85 patients)
DEPO-PROVERA (83 patients)
SUBOXONE (83 patients)
TOPAMAX (82 patients)
LORAZEPAM (81 patients)
OMEPRAZOLE (80 patients)
AMOXICILLIN (78 patients)
THALOMID (78 patients)
LANTUS (77 patients)
EFFEXOR XR (77 patients)
ALBUTEROL (77 patients)
BETASERON (76 patients)
DIAZEPAM (76 patients)
ARAVA (75 patients)
PROZAC (74 patients)
IRON (73 patients)
WELLBUTRIN (73 patients)
GLUCOPHAGE (71 patients)
LEVOTHYROXINE SODIUM (69 patients)
LOVENOX (69 patients)
OSELTAMIVIR (68 patients)
NEURONTIN (68 patients)
TEGRETOL (68 patients)
LETAIRIS (66 patients)
INSULIN (66 patients)
BIRTH CONTROL PILLS (66 patients)
AMBIEN (65 patients)
ORTHO EVRA (65 patients)
VITAMIN D (64 patients)
AMITRIPTYLINE HCL (63 patients)
KLONOPIN (63 patients)
CYMBALTA (63 patients)
XANAX (63 patients)
ZOFRAN (62 patients)
HUMIRA (62 patients)
CELEBREX (61 patients)
PAROXETINE HCL (60 patients)
BACTRIM (60 patients)
VITAMIN AND MINERAL PRENATAL SUPPLEMENT W/ FOLIC ACID CAP (59 patients)
NOVORAPID (58 patients)
CONTRACEPTIVE (57 patients)
ZYRTEC (57 patients)
CEREZYME (56 patients)
KEPPRA XR (56 patients)
SORIATANE (56 patients)
CARBAMAZEPINE (56 patients)
FLUOXETINE (56 patients)
MULTI-VITAMIN (54 patients)
PRENATAL VITAMINS /01549301/ (54 patients)
DEPAKOTE (53 patients)
CYCLOPHOSPHAMIDE (53 patients)
LEVEMIR (53 patients)
DEPAKENE (52 patients)
MIRTAZAPINE (51 patients)
HUMALOG (51 patients)
HYDROCHLOROTHIAZIDE (51 patients)
TOPIRAMATE (50 patients)
PEGASYS (50 patients)
LAMIVUDINE + ZIDOVUDINE (50 patients)
ZANTAC (50 patients)
ADVAIR DISKUS 100/50 (49 patients)
ASCORBIC ACID (49 patients)
ACITRETIN (48 patients)
XOLAIR (48 patients)
LABETALOL HCL (47 patients)
STOCRIN TABS (47 patients)
NEXIUM (46 patients)
BIRTH CONTROL PILLS (ORAL CONTRACEPTIVE NOS) (46 patients)
NELFINAVIR (45 patients)
RIVOTRIL (45 patients)
ORAL CONTRACEPTIVE NOS (44 patients)
RISPERDAL (44 patients)
IMPLANON (43 patients)
PROGESTERONE (43 patients)
GABAPENTIN (43 patients)
LORTAB (43 patients)
TRILEPTAL (43 patients)
CALCIUM (42 patients)
KIVEXA (42 patients)
FERROUS SULFATE TAB (42 patients)
SUBUTEX (41 patients)
EPZICOM (41 patients)
LISINOPRIL (41 patients)
PRILOSEC (41 patients)
COPAXONE (40 patients)
GONAL-F (40 patients)
PROPRANOLOL (40 patients)
IMMUNOSUPPRESSIVE AGENTS (40 patients)
CYCLOSPORINE (39 patients)
PERCOCET (39 patients)
ORAL CONTRACEPTIVE (39 patients)
LASIX (39 patients)
EMTRIVA (38 patients)
WARFARIN SODIUM (38 patients)
MIFEPRISTONE (38 patients)
ATENOLOL (38 patients)
PEG-INTRON (37 patients)
BENADRYL (37 patients)
OLANZAPINE (37 patients)
TRAMADOL HCL (37 patients)
ZITHROMAX (37 patients)
RIBAVIRIN (36 patients)
ATAZANAVIR SULFATE (36 patients)
HERCEPTIN (36 patients)
VIMPAT (36 patients)
BETAMETHASONE (35 patients)
METHADONE HCL (35 patients)
SERTRALINE HYDROCHLORIDE (35 patients)
ALLEGRA (35 patients)
TAZORAC (34 patients)
LOPINAVIR (34 patients)
ASACOL (34 patients)
REVATIO (34 patients)
CIPRALEX (ESCITALOPRAM) (34 patients)
ACYCLOVIR (34 patients)
TRAZODONE HCL (34 patients)
ISENTRESS (34 patients)
ALPRAZOLAM (34 patients)
DOSTINEX (34 patients)
PROMETHAZINE (33 patients)
MAXALT (33 patients)
LOPINAVIR AND RITONAVIR (33 patients)
VICODIN (33 patients)
TENOFOVIR DISOPROXIL FUMARATE (33 patients)
REBETOL (33 patients)
CLOMIPHENE CITRATE (32 patients)
SPRYCEL (32 patients)
EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (32 patients)
XYREM (32 patients)
DIGOXIN (32 patients)
Most common side effects for patients taking SALOSPIR (ACETYLSALICYLIC ACID):
PLATELET COUNT DECREASED (3 patients)
NEUTROPENIA (3 patients)
DRUG EXPOSURE DURING PREGNANCY (3 patients)
INFECTION (2 patients)
OSTEONECROSIS (2 patients)
DYSPNOEA (2 patients)
DYSPNOEA EXERTIONAL (2 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (2 patients)
OEDEMA (2 patients)
HEADACHE (2 patients)
GRAND MAL CONVULSION (2 patients)
HAEMOPTYSIS (2 patients)
POST PROCEDURAL COMPLICATION (2 patients)
PREGNANCY (2 patients)
ALANINE AMINOTRANSFERASE INCREASED (2 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (2 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (2 patients)
THROMBOCYTOPENIA (2 patients)
RESPIRATORY TRACT HAEMORRHAGE (2 patients)
RENAL IMPAIRMENT (2 patients)
PULMONARY HYPERTENSION (2 patients)
LYMPHOCYTE PERCENTAGE INCREASED (1 patients)
LUNG INFECTION (1 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (1 patients)
LEUKOPENIA (1 patients)
JOINT DISLOCATION (1 patients)
ISCHAEMIC STROKE (1 patients)
INJECTION SITE REACTION (1 patients)
NAUSEA (1 patients)
PREMATURE LABOUR (1 patients)
TRANSAMINASES INCREASED (1 patients)
NO THERAPEUTIC RESPONSE (1 patients)
PHOBIA (1 patients)
PANNICULITIS (1 patients)
OEDEMA MOUTH (1 patients)
ORTHOSTATIC HYPOTENSION (1 patients)
SUBARACHNOID HAEMORRHAGE (1 patients)
VISUAL DISTURBANCE (1 patients)
INCONTINENCE (1 patients)
HYPOKALAEMIA (1 patients)
DISCOMFORT (1 patients)
DEPRESSED MOOD (1 patients)
CRYING (1 patients)
CRANIOTOMY (1 patients)
COUGH (1 patients)
CORONARY ANGIOPLASTY (1 patients)
CEREBRAL INFARCTION (1 patients)
CAESAREAN SECTION (1 patients)
BLOOD TRIGLYCERIDES INCREASED (1 patients)
BLOOD CHOLESTEROL INCREASED (1 patients)
ASPARTATE AMINOTRANSFERASE ABNORMAL (1 patients)
ALANINE AMINOTRANSFERASE ABNORMAL (1 patients)
DIZZINESS (1 patients)
DUODENAL ULCER (1 patients)
HYPOGLYCAEMIA (1 patients)
HYPERSENSITIVITY (1 patients)
HEMIPARESIS (1 patients)
GASTROENTERITIS (1 patients)
HAEMOGLOBIN DECREASED (1 patients)
HAEMATOMA (1 patients)
HAEMATOCRIT INCREASED (1 patients)
HAEMATOCRIT DECREASED (1 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (1 patients)
GASTRIC ULCER (1 patients)
GAMMA-GLUTAMYLTRANSFERASE ABNORMAL (1 patients)
ECCHYMOSIS (1 patients)
ABNORMAL DREAMS (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for SALOSPIR (ACETYLSALICYLIC ACID)


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about PREGNANCY and SALOSPIR (ACETYLSALICYLIC ACID), post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking SALOSPIR (ACETYLSALICYLIC ACID), post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in SALOSPIR (ACETYLSALICYLIC ACID). This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for SALOSPIR (ACETYLSALICYLIC ACID) experts. If you are a healthcare provider experienced in prescribing SALOSPIR (ACETYLSALICYLIC ACID), please register here.
© 2014 FactMed, Inc
Privacy Policy
Terms of Use